1 – 3 of 3
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2006
-
Mark
Health-related quality of life in multiple system atrophy
(
- Contribution to journal › Article
- 2005
-
Mark
Treatment of end-of-dose wearing-off in Parkinson's disease: Stalevo (R) (levodopa/carbidopa/entacapone) and levodopa/DDCI given in combination with Comtess (R)/Comtan (R) (Entacapone) provide equivalent improvements in symptom control superior to that of traditional levodopa/DDCI treatment
(
- Contribution to journal › Article
-
Mark
The European Multiple System Atrophy-Study Group (EMSA-SG)
(
- Contribution to journal › Article